GAIA AG is a research-based public health company that has been developing and implementing innovations in the field of care management and e/m-Health since 1997. With a focus on scientific, technological and therapeutic expertise, GAIA offers evidence-based digital therapies developed in cooperation with leading international experts.
GAIA's mission is to improve healthcare through digital innovations and strengthen patient orientation. The company is committed to integrating digital therapies into healthcare and promoting the development of evidence-based digital therapy systems.
GAIA is actively involved in political and social debates to promote digitization in healthcare. It participates in EU strategies such as the "Digital Europe" program and advocates for clear regulatory frameworks to improve access to digital health solutions.
GAIA has been a member of the Verband forschender Pharma-Unternehmen (vfa) since 2023 and has opened a research site in Cambridge, USA. These partnerships underscore the company's commitment to innovation in healthcare. GAIA also offers training courses and webinars to promote the integration of digital therapies into everyday practice.
